
艾思科蓝公众号
个人简述:
多年来一直专注于药物化学和化学生物学领域研究,目前开展的课题包括药物设计与合成、基于离子跨膜转运机制的抗肿瘤抗菌药物的合成及生物活性。迄今,先后承担了国家自然基金面上项目、教育部新世纪优秀人才支持计划以及广东省高等学校人才引进专项等多项科研课题,在J. Am. Chem. Soc., Chem. Commun., Bioconjugate Chem., J. Org. Chem.以及Org. Biomol. Chem.等国际学术刊物上发表了英文SCI论文97篇,并被多个学术刊物详细报道。
科研工作:
2015年以来发表的主要论文:(1) Eur. J. Med. Chem. 2018, 152, 115–125.(2) Mini-Rev. Org. Chem. 2018, 15 (2), 148–156.(3) J. Org. Chem. 2017, 82 (24), 13368–13375.(4) Org. Biomol. Chem. 2017, 15 (48), 10221–10229.(5) ACS Appl. Mater. Interfaces, 2017, 9 (47), 41378–41386.(6) Mini-Rev. Med. Chem. 2017, 17 (14), 1398–1405.(7) Org. Biomol. Chem. 2017, 15, 4077–4080.(8) Bioorg. Med. Chem. Lett. 2017, 27, 1999–2002.(9) Org. Biomol. Chem. 2017, 15, 2831–2840.(10) Org. Biomol. Chem. 2016, 14, 8232– 8236.(11) Bioorg. Med. Chem. Lett. 2016, 26, 3665–3668.(12) Bioorg. Med. Chem. Lett. 2016, 26, 2442–2445.(13) ACS Comb. Sci. 2016, 18 (8), 475–481.(14) Dalton Trans. 2016, 45, 5092–5100.(15) Org. Biomol. Chem. 2016, 14, 191–197.(16) Chem. Commun. 2016, 52, 132–135.(17) Anal. Chem. 2015, 87 (24), 12206–12214.F(18) Org. Biomol. Chem. 2015, 13, 11761–11769.(19) Dalton Transactions 2015, 44, 13369–13377.(20) Bioorg. Med. Chem. Lett. 2015, 25, 1872–1875.(21) RSC Adv. 2015, 5, 32990–32993.(22) Aust. J. Chem. 2015, 68, 493–499.(23) Inorg. Chim. Acta 2015, 429, 168–173.(24) Bioorg. Med. Chem. Lett. 2015, 25, 745–748.(25) Eur. J. Med. Chem. 2015, 90, 251–257.
资料审核中
您的资料已提交成功!
我们的工作人员会将会在3-5个工作日内和您联系